DSCI News Alert Derma Sciences (DSCI) 9.08 12/25/2014 10:09:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Derma Sciences (DSCI) 9.08 $DSCI

Insider Trading Alert - DGI, CME And DSCI Traded By Insiders
at The Street - Wed Dec 17, 10:41AM CST
Stocks with insider trader activity include DGI, CME and DSCI
DSCI: 9.08 (+0.43), CME: 90.58 (-2.14), DGI: 30.85 (+0.27)

New Consensus Guidelines and Practical Recommendations Published on the Optimal Use of Off-Loading in Diabetic Foot Ulcer Treatment
PR Newswire - Wed Dec 17, 8:03AM CST
Relieving pressure on the foot through the use of "off-loading" improves healing outcomes and reduces complications in patients with diabetic foot ulcers (DFUs), according to consensus guidelines published today in the Journal of the American Podiatric Medical Association. "The Management of Diabetic Foot Ulcers Through Optimal Off-Loading - Building Consensus Guidelines and Practical Recommendations to Improve Outcomes," was authored by a multidisciplinary panel of nine experts who were supported by Derma Sciences, Inc (Nasdaq: DSCI). The document was developed to provide evidence-based consensus on the optimal use of off-loading as treatment for DFUs, a debilitating and costly condition that can lead to amputation of the foot and other lower extremities.
DSCI: 9.08 (+0.43)

North America Traditional Wound Management Market Outlook to 2020 - Key Vendors are Medline Industries, Inc., Johnson & Johnson and Covidien plc
M2 - Mon Dec 08, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/r555k6/north_america) has announced the addition of the "North America Traditional Wound Management Market Outlook to 2020" report to their offering. "North America Traditional Wound Management Market Outlook to 2020", provides key market data on the North America Traditional Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Traditional Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size data for Traditional Wound Management market segments - Gauzes, Sponges, Bandages, Abdominal Pads and Gauze Sponges. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Traditional Wound Management market. - Global corporate-level profiles of key companies operating within the North America Traditional Wound Management market. - Key players covered include Medline Industries, Inc., Johnson & Johnson and Covidien plc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Traditional Wound Management Market, North America 4 Traditional Wound Management Market, Canada 5 Traditional Wound Management Market, Mexico 6 Traditional Wound Management Market, United States 7 Overview of Key Companies in North America Traditional Wound Management Market 8 Traditional Wound Management Market Pipeline Products 9 Recent Developments 10 Appendix Companies Mentioned - B. Braun Melsungen AG - BSN medical GmbH - Covidien plc - Cypress Medical Products, LLC - DUKAL Corporation - Derma Sciences, Inc. - Johnson & Johnson - Lohmann & Rauscher GmbH & Co. KG - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG For more information visit http://www.researchandmarkets.com/research/r5...th_america
DSCI: 9.08 (+0.43), JNJ: 104.59 (+0.31)

Insider Trading Alert - FR, BHB And DSCI Traded By Insiders
at The Street - Mon Dec 08, 9:15AM CST
Stocks with insider trader activity include FR, BHB and DSCI
DSCI: 9.08 (+0.43), FR: 20.98 (-0.05), BHB: 30.54 (-0.01)

Insider Trading Alert - MNTA, DOC And DSCI Traded By Insiders
at The Street - Fri Nov 28, 9:15AM CST
Stocks with insider trader activity include MNTA, DOC and DSCI
DSCI: 9.08 (+0.43), DOC: 16.67 (unch), MNTA: 11.42 (-0.06)

Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry
M2 - Wed Nov 26, 6:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/lrwbbc/global_advanced) has announced the addition of the "Global Advanced Wound Care and Closure Market Report 2013-2020 - Types, Applications, End User Analysis of the $20 Billion Industry" report to their offering. The global advanced wound care and closure market will reach $20.5 billion by 2020 Negative Pressure Wound Therapy (NPWT) has emerged as a highly effective therapy for advanced wound management. NPWT promotes wound healing through the application of negative pressure on the wound via foam dressings. Strong growth is anticipated in NPWT segment during the forecast period and would reach $3.7 billion by 2020. Chronic wounds are hard to heal, which take substantial time to heal and are expensive to treat. Advanced wound care and closure products are increasingly gaining popularity as standard solutions for treating chronic wounds. Traditional products are being increasingly substituted with advanced products, mainly due to their effectiveness in managing wounds by promoting faster healing. Lifestyle diseases are the cause of chronic wounds such as diabetic foot ulcer, venous leg ulcer, pressure ulcer etc. Products that treat these ulcers are gaining prominence; therefore, the major application of these products is in treating different kinds of ulcers. The advanced wound care and closure market for ulcer treatment is expected to grow over $7.8 billion by 2020 with diabetic foot ulcer management segment being prominent among all other segments. Key advanced wound care and closure manufacturers such as Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International, Coloplast have adopted merger and acquisition and product launch as key developmental strategies in order to implement existing technologies with new products and capitalize unexplored markets. Scope of the Report MARKET BY TYPE - Advanced Wound closure - Haemostatic and sealing agents - Fibrin Sealant - Surgical Sealant - Gelatin-based Sealant - Human Fibrinogen and Thrombin Fleece - Topical Tissue Adhesive - Wound closure devices - Mechanical stapling device - Ligating clips - Wound closure strips - Others - Advanced Wound care - Moist Wound dressings - Films - Foams - Hydrocolloids - Hydrogels - Collagen - Alginates - Silver Wound Dressings - Active Wound care - Skin substitutes - Growth factors - Therapy devices - Negative Pressure Wound Therapy - Pressure relief devices MARKET BY APPLICATION - Burns - Ulcers - Pressure ulcers - Diabetic ulcers - Venous leg ulcers - Arterial ulcers - Surgical Wounds MARKET BY END-USER - Hospitals and Community Health Services - Home Healthcare Companies Mentioned - 3M - Baxter International - BSN medical - Coloplast - ConvaTech - Covidien - Derma Sciences - Integra LifeSciences - Kinetic Concepts - Smith and Nephew For more information visit http://www.researchandmarkets.com/research/lr...l_advanced
DSCI: 9.08 (+0.43), BAX: 74.45 (-0.04)

Derma Sciences To Participate in Two Upcoming Investor Conferences in December
Business Wire - Tue Nov 25, 1:05PM CST
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that management will be participating in two upcoming investor conferences.
DSCI: 9.08 (+0.43)

North America Advanced Wound Management Market Outlook 2020: Key Vendors are 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc.
M2 - Tue Nov 18, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/qm5kwn/north_america) has announced the addition of the "North America Advanced Wound Management Market Outlook to 2020" report to their offering. "North America Advanced Wound Management Market Outlook to 2020", provides key market data on the North America Advanced Wound Management market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Advanced Wound Management market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Scope - Market size data for Advanced Wound Management market segments - Semi-Permeable Films, Foams, Hydrofibres, Hydrocolloids, Hydrogels, Alginates, Collagens, Wound Contact Layers and Superabsorbents. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Advanced Wound Management market. - Global corporate-level profiles of key companies operating within the North America Advanced Wound Management market. - Key players covered include 3M Health Care Ltd., Smith & Nephew Plc and ConvaTec Inc. Companies Mentioned - 3M Health Care Ltd. - BSN medical GmbH - Coloplast A/S - ConvaTec Inc. - Covidien plc - Derma Sciences, Inc. - Hollister Incorporated - Laboratoires Urgo S.A. - Medline Industries, Inc. - Molnlycke Health Care AB - Paul Hartmann AG - Smith & Nephew Plc - Systagenix Wound Management Limited For more information visit http://www.researchandmarkets.com/research/qm...th_america
DSCI: 9.08 (+0.43), SNN: 38.18 (+0.14)

Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum
Business Wire - Fri Nov 14, 8:21AM CST
Derma Sciences, Inc. (Nasdaq SCI), a tissue regeneration company focused on advanced wound and burn care, today announced that Edward J. Quilty, the Company's chairman and chief executive officer will participate in a "Fireside Chat" at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:30 a.m. ET. The conference will be held at the Westin Grand Central in New York City
DSCI: 9.08 (+0.43)

Canada Compression Therapy Market Outlook to 2020: SIGVARIS, Inc., Covidien plc and BSN medical GmbH Leads the Market
M2 - Thu Nov 13, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5g6ff/canada) has announced the addition of the "Canada Compression Therapy Market Outlook to 2020" report to their offering. "Canada Compression Therapy Market Outlook to 2020", provides key market data on the Canada Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Canada Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Smith & Nephew Plc - 3M Health Care Ltd. - Mego Afek AC LTd. - DJO Global, Inc. - Bio Compression Systems, Inc. - medi GmbH & Co. KG - ConvaTec Inc. - Lohmann & Rauscher GmbH & Co. KG - Systagenix Wound Management Limited - B. Braun Melsungen AG - Derma Sciences, Inc. - Medline Industries, Inc. - Laboratoires Urgo S.A. - Talley Group Limited - ArjoHuntleigh - Molnlycke Health Care AB - Gloria Med S.p.A. - Cardinal Health, Inc. - Juzo USA For more information visit http://www.researchandmarkets.com/research/n5g6ff/canada
DSCI: 9.08 (+0.43), SNN: 38.18 (+0.14), CAH: 82.07 (+0.15)

Brazil Compression Therapy Market Outlook to 2020 - Key Players are SIGVARIS, Inc., Covidien plc and BSN medical GmbH
M2 - Thu Nov 13, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/4n655s/brazil) has announced the addition of the "Brazil Compression Therapy Market Outlook to 2020" report to their offering. "Brazil Compression Therapy Market Outlook to 2020", provides key market data on the Brazil Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Compression Therapy market. - Global corporate-level profiles of key companies operating within the Brazil Compression Therapy. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages and Anti Embolism Stockings) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - 3M Health Care Ltd. - Daesung Maref Co., Ltd - Lohmann & Rauscher GmbH & Co. KG - medi GmbH & Co. KG - Salzmann AG - Medline Industries, Inc. - Paul Hartmann AG - Laboratoires Innothera - Smith & Nephew Plc - Derma Sciences, Inc. - Mego Afek AC LTd. - ArjoHuntleigh - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/4n655s/brazil
DSCI: 9.08 (+0.43), SNN: 38.18 (+0.14)

North America Compression Therapy Market Outlook to 2020: Key Players are Covidien plc, BSN medical GmbH and SIGVARIS, Inc.
M2 - Wed Nov 12, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/z9bhqr/north_america) has announced the addition of the "North America Compression Therapy Market Outlook to 2020" report to their offering. "North America Compression Therapy Market Outlook to 2020", provides key market data on the North America Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Compression Therapy market. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Market Segments - Static Compression Therapy (Compression Garments (Upper and Lower Compression Garments), Compression Bandages, Anti Embolism Stockings and Diabetic Compression Socks) - Pneumatic Compression Therapy (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps (Segmented Pneumatic Compression Pumps without Gradient and with Calibrated Gradient) and Pneumatic Compression Sleeves). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Compression Therapy Market, North America 4 Compression Therapy Market, Canada 5 Compression Therapy Market, Mexico 6 Compression Therapy Market, United States 7 Overview of Key Companies in North America Compression Therapy Market 8 Recent Developments 9 Appendix Companies Mentioned - SIGVARIS, Inc. - Covidien plc - BSN medical GmbH - Medline Industries, Inc. - THUASNE SA - 3M Health Care Ltd. - Juzo USA - DJO Global, Inc. - Bio Compression Systems, Inc. - Mego Afek AC LTd. - medi GmbH & Co. KG - ArjoHuntleigh - Salzmann AG - Derma Sciences, Inc. - B. Braun Melsungen AG - Lohmann & Rauscher GmbH & Co. KG - Paul Hartmann AG - Laboratoires Innothera For more information visit http://www.researchandmarkets.com/research/z9...th_america
DSCI: 9.08 (+0.43)

Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 12:52PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
CLUB: 5.90 (-0.07), CBPO: 64.79 (-0.59), DSCI: 9.08 (+0.43), HYGS: 13.33 (+0.06), MYGN: 36.50 (+0.28), MCEP: 6.07 (-0.12), HIIQ: 7.51 (-0.16), HYG.TO: 15.50 (-0.16), SLTC: 5.51 (-0.09), ASEI: 51.61 (+0.05), MTEX: 28.96 (unch), PLNR: 7.04 (-0.15)

Derma Sciences' (DSCI) CEO Ed Quilty on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:37PM CST

DSCI: 9.08 (+0.43)

Derma Sciences lowers sales guidance after Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 12:28PM CST

DSCI: 9.08 (+0.43)

Diabetic Foot Ulcers Therapeutics Pipeline Report H2 2014 - Analysis of 26 Companies & 37 Drug Profiles
M2 - Mon Nov 10, 10:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/b997sg/diabetic_foot) has announced the addition of the "Diabetic Foot Ulcers - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Derma Sciences, Inc. - GlaxoSmithKline plc - CardioVascular BioTherapeutics, Inc. - Stratatech Corporation - Tissue Med Biosciences - Reliance Life Sciences Pvt. Ltd. - Celgene Corporation - Kaken Pharmaceutical Co., Ltd. - CytoTools AG - NovaLead Pharma Pvt. Ltd. - FirstString Research, Inc. - Lumosa Therapeutics Co., Ltd. - CoDa Therapeutics, Inc. - Adocia - Plurogen Therapeutics, Inc. - EyeGene, Inc. - Izun Pharmaceuticals Corporation - MacroCure - Royer Biomedical, Inc. - Oneness Biotech Co., Ltd. - Aprogen, Inc. - Pergamum AB - Dipexium Pharmaceuticals LLC - Kasiak Research Pvt. Ltd. - Innovaxis - Grupo Praxis Pharmaceutical SA Drug Profiles - pexiganan acetate - DermaPro - trafermin - Recombinant Protein to Agonize Platelet Derived Growth Factor Receptor for Metabolic and Dermatology Diseases - ON-101 - DSC-127 - CureXcell - Granexin - Vivefoot - ReliDerm-DT - CVBT-141B - CODA-001 - PX-070101 - IZN-6D4 - CSTC-1 - PluroGel N - esmolol hydrochloride - gentamicin sulfate - GSK-1278863 - PDA-002 - TMBP-3 - coagulation factor XIVa (human) - AP-102 - Cyndacel-M - EG-Decorin - STD-06 - Nu-2 - Nu-3 - MT-003 - Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers For more information visit http://www.researchandmarkets.com/research/b9...betic_foot
DSCI: 9.08 (+0.43), DPRX: 11.25 (-0.07), GSK: 42.85 (+0.11), CELGZ: 3.34 (-0.01)

Derma Sciences posts 3Q loss
Automated Insights - Mon Nov 10, 6:39AM CST
PRINCETON, N.J. (AP) _ Derma Sciences Inc. (DSCI) on Monday reported a loss of $11.2 million, or 45 cents per share, in its third quarter.
DSCI: 9.08 (+0.43)

Derma Sciences misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:32AM CST

DSCI: 9.08 (+0.43)

Derma Sciences Reports Third Quarter Financial Results
Business Wire - Mon Nov 10, 6:30AM CST
--Conference call begins at 11:00 a.m. Eastern time today
DSCI: 9.08 (+0.43)

The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq SCI-Free Report).
DSCI: 9.08 (+0.43), UNIS: 3.19 (+0.03), MDT: 74.08 (+0.31), SHPG: 209.29 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 86

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 121

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 87

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading

Top 5 Most Recently Viewed Articles

American Teachers Alliance Initiates Empowering Programs for Students

Updated Category News Views 143

Empowering Future Educators with College Chapters In a progressive move to inspire and support the upcoming generation of teachers, the American Teachers Alliance (ATA) has launched a significant initiative aimed at engaging college students across universities. This initiative introduces college student chapters, fostering a community where aspiring educators can enhance...

Continue Reading
Enhancing Enterprise Collaboration: Progress ShareFile and Microsoft 365

Updated Category News Views 190

Introduction to Progress ShareFile's New Features Progress, a leading provider of AI-driven digital experience and infrastructure software, is excited to announce significant advancements to its ShareFile platform. The recent updates mark a transformative leap in how enterprises collaborate using Microsoft 365, empowering teams to work more securely and efficiently. Deep...

Continue Reading
Shareholder Alert: Investigations on Major Mergers for 2025

Updated Category News Views 314

Investigating Significant Mergers in 2025 In the financial landscape, the merging of companies can significantly impact shareholders. Recognizing the importance of every shareholder's voice, we delve into several notable mergers that are under scrutiny as we approach votes critical to shareholders. As many companies opt for merger routes, understanding the implications of...

Continue Reading
Explore the Vibrant Daylight Shows Series in NYC's Hotspots

Updated Category News Views 181

Unveiling the Daylight Shows at Daylight Studio Experience the vibrant world of creativity at Daylight Studio, a prominent event venue nestled in two of New York City's most dynamic areas, Hudson Yards and Flatiron. With years of experience in supporting film, fashion, and artistic endeavors, Daylight Studio has secured its place as a go-to location for creatives and...

Continue Reading
Ventyx Biosciences Begins Phase 2a Trial for Parkinson’s Treatment

Updated Category News Views 138

Ventyx Biosciences Begins Phase 2a Trial for VTX3232 Ventyx Biosciences, Inc. (Nasdaq: VTYX), a company focused on creating innovative oral treatments for various inflammatory diseases, has announced the start of dosing for its Phase 2a clinical trial of VTX3232. This important trial is centered on individuals who have been diagnosed with the early stages of Parkinson’s...

Continue Reading